Anthelmintic efficacy of glycolipid biosurfactant produced by Pseudomonas plecoglossicida: an insight from mutant and transgenic forms of Caenorhabditis elegans

  • Sabarinathan DevarajEmail author
  • Mohankumar Amirthalingam
  • Poorna Chandrika Sabapathy
  • Shanmugam Govindan
  • Sundararaj Palanisamy
  • Preethi KathirvelEmail author
Original Paper


The current research focuses on the production and characterization of glycolipid biosurfactant (GB) from Pseudomonas plecoglossicida and its anthelmintic activity against Caenorhabditis elegans. The GB was purified and characterized by Fourier Transform Infrared Spectroscopy (FTIR) and Gas Chromatography and Mass Spectrometry (GC–MS) analysis. Anthelmintic activity of GB was studied at six different pharmacological doses from 10 to 320 µg/mL on C. elegans. Exposure of different developmental stages (L1, L2, L3, L4 and adult) of C. elegans to the GB reduced the survivability of worms in a dose and time-dependent manner. Adult and L4 worms were least susceptible, while L1, L2 and L3 were more susceptible to GB when compared to the untreated control. An increased exposure period drastically reduced the survival rate of worms and reduction in LC50 value. The GB significantly inhibited the development of C. elegans with an IC50 value of 53.14 µg/mL and even reduced the adult body length and egg hatching. Fecundity rate of the worms treated with GB at 20, 40 and 80 µg/mL decreased from 261.90 ± 3.21 to 239.70 ± 5.58, 164.20 ± 5.94 and 44.80 ± 6.22 eggs per worm, respectively. Besides the toxicological effects, prolonged exposure to GB significantly decreased (p ≤ 0.0001) the lifespan of wild type worms under standard laboratory conditions. Additionally, GB was found to be lethal towards ivermectin and albendazole resistant C. elegans strains. Overall, the data indicated that the GB extracted from P. plecoglossicida could be utilized for the control of non-susceptible and resistant gastrointestinal nematodes towards broad spectrum anthelmintic drugs, ivermectin and albendazole.


Anthelmintic activity Caenorhabditis elegans Drug resistance Glycolipid biosurfactant Pseudomonas plecoglossicida 



Authors are grateful to Caenorhabditis Genetic Center which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440) for providing all C. elegans strain. The author DS acknowledges Bharathiar University for University Research Fellowship, Grant No: C2/9214/URF/2014.

Supplementary material

10532_2018_9831_MOESM1_ESM.docx (1.5 mb)
Supplementary material 1 (DOCX 1521 kb)


  1. Abdel-Mawgoud AM, Lépine F, Déziel E (2010) Rhamnolipids: Diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol 86:1323–1336CrossRefPubMedPubMedCentralGoogle Scholar
  2. Banat IM, Franzetti A, Gandolfi I et al (2010) Microbial biosurfactants production, applications and future potential. Appl Microbiol Biotechnol 87:427–444CrossRefPubMedGoogle Scholar
  3. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71–94. PubMedPubMedCentralGoogle Scholar
  4. Bull K, Cook A, Hopper NA et al (2007) Effects of the novel anthelmintic emodepside on the locomotion, egg-laying behaviour and development of Caenorhabditis elegans. Int J Parasitol 37:627–636. CrossRefPubMedGoogle Scholar
  5. Bürglin TR, Lobos E, Blaxter ML (1998) Caenorhabditis elegans as a model for parasitic nematodes. Int J Parasitol 28:395–411. CrossRefPubMedGoogle Scholar
  6. Charles Oluwaseun A, Julius Kola O, Mishra P et al (2017) Characterization and optimization of a rhamnolipid from Pseudomonas aeruginosa C1501 with novel biosurfactant activities. Sustain Chem Pharm 6:26–36. CrossRefGoogle Scholar
  7. Chaweeborisuit P, Suriyonplengsaeng C, Suphamungmee W et al (2016) Nematicidal effect of plumbagin on Caenorhabditis elegans: a model for testing a nematicidal drug. Zeitschrift fur Naturforsch Sect C J Biosci 71:121–131. Google Scholar
  8. Das D, Ashoka D, Aradhya R, Inamdar M (2008) Gene expression analysis in post-embryonic pericardial cells of Drosophila. Gene Expr Patterns 8:199–205. CrossRefPubMedGoogle Scholar
  9. Dent JA, Smith MM, Vassilatis DK, Avery L (2000) The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97:2674–2679. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Devagi G, Shanmugam G, Mohankumar A et al (2017) Caenorhabditis elegans as a model for exploring the efficacy of synthesized organoruthenium complexes for aging and Alzheimer’s disease a neurodegenerative disorder: a systematic approach. J Organomet Chem 838:12–23. CrossRefGoogle Scholar
  11. Driscoll M, Dean E, Reilly E et al (1989) Genetic and molecular analysis of a Caenorhabditis elegans beta-tubulin that conveys benzimidazole sensitivity. J Cell Biol 109:2993–3003. CrossRefPubMedGoogle Scholar
  12. Fabian TJ, Johnson TE (1994) Production of age-synchronous mass cultures of Caenorhabditis elegans. J Gerontol 49:B145–B156. CrossRefPubMedGoogle Scholar
  13. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMedGoogle Scholar
  14. Franzetti A, Tamburini E, Banat IM (2010) Applications of biological surface active compounds in remediation technologies. Adv Exp Med Biol 672:121–134. CrossRefPubMedGoogle Scholar
  15. Geary TG, Thompson DP (2001) Caenorhabditis elegans: how good a model for veterinary parasites? Vet Parasitol 101:371–386CrossRefPubMedGoogle Scholar
  16. Hošková M, Schreiberová O, Ježdík R, Chudoba J, Masák J, Sigler K, Řezanka T (2013) Characterization of rhamnolipids produced by non-pathogenic Acinetobacter and Enterobacter bacteria. Bioresour Technol 130:510–516CrossRefPubMedGoogle Scholar
  17. Kampkötter A, Nkwonkam CG, Zurawski RF et al (2007) Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 234:113–123. CrossRefPubMedGoogle Scholar
  18. Kaplan RM (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 20:477–481CrossRefPubMedGoogle Scholar
  19. Maddikeri GL, Gogate PR, Pandit AB (2015) Improved synthesis of sophorolipids from waste cooking oil using fed batch approach in the presence of ultrasound. Chem Eng J 263:479–487. CrossRefGoogle Scholar
  20. Monteiro AS, Coutinho JOPA, Júnior AC et al (2009) Characterization of new biosurfactant produced by Trichosporon montevideense CLOA 72 isolated from dairy industry effluents. J Basic Microbiol 49:553–563. CrossRefPubMedGoogle Scholar
  21. Mukherjee S, Das P, Sivapathasekaran C, Sen R (2008) Enhanced production of biosurfactant by a marine bacterium on statistical screening of nutritional parameters. Biochem Eng J 42:254–260. CrossRefGoogle Scholar
  22. Page AP, Johnstone IL (2007) The cuticle. WormBook. PubMedPubMedCentralGoogle Scholar
  23. Patil S, Nikam M, Anokhina T et al (2017) Multi-stress tolerant plant growth promoting Pseudomonas spp. MCC 3145 producing cytostatic and fungicidal pigment. Biocatal Agric Biotechnol 10:53–63. Google Scholar
  24. Perry BD, Randolph TF (1999) Improving the assessment of the economic impact of parasitic diseases and of their control in production animals. In: Veterinary Parasitology. pp 145–168Google Scholar
  25. Sabapathy PC, Devaraj S, Kathirvel P (2017) Parthenium hysterophorus: low cost substrate for the production of polyhydroxyalkanoates. Curr Sci 112:2106–2111. CrossRefGoogle Scholar
  26. Sajid M, Azim MK (2012) Characterization of the nematicidal activity of natural honey. J Agric Food Chem 60:7428–7434. CrossRefPubMedGoogle Scholar
  27. Sant’anna V, Vommaro RC, de Souza W (2013) Caenorhabditis elegans as a model for the screening of anthelminthic compounds: ultrastructural study of the effects of albendazole. Exp Parasitol 135:1–8.
  28. Shanmugam G, Mohankumar A, Kalaiselvi D et al (2017) Diosgenin a phytosterol substitute for cholesterol, prolongs the lifespan and mitigates glucose toxicity via DAF-16/FOXO and GST-4 in Caenorhabditis elegans. Biomed Pharmacother 95:1693–1703. CrossRefPubMedGoogle Scholar
  29. Silva EJ, Rocha e Silva NMP, Rufino RD, et al (2014) Characterization of a biosurfactant produced by Pseudomonas cepacia CCT6659 in the presence of industrial wastes and its application in the biodegradation of hydrophobic compounds in soil. Colloids Surf B Biointerfaces 117:36–41.
  30. Singh V (2012) Biosurfactant—isolation, production, purification & significance. Int J Sci Res Publ 2:2250–3153Google Scholar
  31. Soares da Silva R de CF, Almeida DG, Meira HM, et al (2017) Production and characterization of a new biosurfactant from Pseudomonas cepacia grown in low-cost fermentative medium and its application in the oil industry. Biocatal Agric Biotechnol 12:206–215.
  32. Vatsa P, Sanchez L, Clement C et al (2010) Rhamnolipid biosurfactants as new players in animal and plant defense against microbes. Int J Mol Sci 11:5095–5108. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Vaz DA, Gudiña EJ, Alameda EJ et al (2012) Performance of a biosurfactant produced by a Bacillus subtilis strain isolated from crude oil samples as compared to commercial chemical surfactants. Colloids Surfaces B 89:167–174. CrossRefGoogle Scholar
  34. Wang W, Cai B, Shao Z (2014) Oil degradation and biosurfactant production by the deep sea bacterium Dietzia maris As-13-3. Front Microbiol. Google Scholar
  35. Wolstenholme AJ, Fairweather I, Prichard R et al (2004) Drug resistance in veterinary helminths. Trends Parasitol. 20:469–476CrossRefPubMedGoogle Scholar
  36. Zhao J, Wu Y, Alfred AT et al (2013) Chemical structures and biological activities of rhamnolipid biosurfactants produced by Pseudomonas aeruginosa M14808. J Chem Pharm Res 5:177–182Google Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Microbial BiotechnologyBharathiar UniversityCoimbatoreIndia
  2. 2.Department of ZoologyBharathiar UniversityCoimbatoreIndia

Personalised recommendations